These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24341822)

  • 21. Serum adipokine concentrations in dogs with naturally occurring pituitary-dependent hyperadrenocorticism.
    Cho KD; Paek J; Kang JH; Chang D; Na KJ; Yang MP
    J Vet Intern Med; 2014; 28(2):429-36. PubMed ID: 24372863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism.
    Oda H; Mori A; Shono S; Onozawa E; Sako T
    J Vet Med Sci; 2016 Jun; 78(5):851-4. PubMed ID: 26782012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the use of trilostane in dogs.
    Lemetayer J; Blois S
    Can Vet J; 2018 Apr; 59(4):397-407. PubMed ID: 29606727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.
    Braddock JA; Church DB; Robertson ID; Watson AD
    Aust Vet J; 2003 Oct; 81(10):600-7. PubMed ID: 15080470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs.
    Goy-Thollot I; Péchereau D; Kéroack S; Dezempte JC; Bonnet JM
    J Small Anim Pract; 2002 Nov; 43(11):489-92. PubMed ID: 12463264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.
    Nagata N; Kojima K; Yuki M
    J Vet Intern Med; 2017 Jan; 31(1):22-28. PubMed ID: 27906457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenocorticotropic hormone, but not trilostane, causes severe adrenal hemorrhage, vacuolization, and apoptosis in rats.
    Burkhardt WA; Guscetti F; Boretti FS; Ivos Todesco A; Aldajarov N; Lutz TA; Reusch CE; Sieber-Ruckstuhl NS
    Domest Anim Endocrinol; 2011 Apr; 40(3):155-64. PubMed ID: 21194873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of trilostane treatment on circulating thyroid hormone concentrations in dogs with pituitary-dependent hyperadrenocorticism.
    Kenefick SJ; Neiger R
    J Small Anim Pract; 2008 Mar; 49(3):139-43. PubMed ID: 18086154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cholecystokinin concentrations in dogs with naturally acquired pituitary-dependent hyperadrenocorticism.
    Noh S; Kim HS; Chang J; Kang JH; Chang D; Yang MP
    Am J Vet Res; 2016 Oct; 77(10):1101-7. PubMed ID: 27668581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism.
    Alenza DP; Arenas C; Lopez ML; Melian C
    J Am Anim Hosp Assoc; 2006; 42(4):269-76. PubMed ID: 16822765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma aldosterone concentrations and plasma renin activity in healthy dogs and dogs with hyperadrenocorticism.
    Javadi S; Kooistra HS; Mol JA; Boer P; Boer WH; Rijnberk A
    Vet Rec; 2003 Oct; 153(17):521-5. PubMed ID: 14620551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.
    Aldridge C; Behrend EN; Kemppainen RJ; Lee-Fowler TM; Martin LG; Ward CR; Bruyette D; Pannu J; Gaillard P; Lee HP
    J Vet Intern Med; 2016 Sep; 30(5):1637-1641. PubMed ID: 27425787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
    Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the concentrations of trilostane and ketotrilostane that inhibit ex vivo canine adrenal gland synthesis of cortisol, corticosterone, and aldosterone.
    McGraw AL; Whitley EM; Lee HP; Boothe DM; Behrend EN
    Am J Vet Res; 2011 May; 72(5):661-5. PubMed ID: 21529218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.
    Golinelli S; de Marco V; Leal RO; Barbarossa A; Aniballi C; Maietti E; Tardo AM; Galac S; Fracassi F
    J Vet Intern Med; 2021 Nov; 35(6):2616-2627. PubMed ID: 34672018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trilostane in dogs.
    Ramsey IK
    Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):269-83. PubMed ID: 20219488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.
    Teshima T; Matsumoto H; Okusa T; Uchiyama R; Koyama H
    PLoS One; 2016; 11(11):e0166267. PubMed ID: 27824928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in ultrasonographic appearance of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
    Mantis P; Lamb CR; Witt AL; Neiger R
    Vet Radiol Ultrasound; 2003; 44(6):682-5. PubMed ID: 14703251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Relationship between Cholestatic Disease and Pituitary-Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series.
    Kim KH; Han SM; Jeon KO; Kim HT; Li Q; Ryu MO; Song WJ; Park SC; Youn HY
    J Vet Intern Med; 2017 Mar; 31(2):335-342. PubMed ID: 28064467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of trilostane for the treatment of alopecia X in Alaskan malamutes.
    Leone F; Cerundolo R; Vercelli A; Lloyd DH
    J Am Anim Hosp Assoc; 2005; 41(5):336-42. PubMed ID: 16141187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.